New York, Antibiotic resistance is a phenomenon that occurs when bacteria become resistant to the effects of antibiotics. This means that antibiotics are no longer effective at killing off the bacteria, and the infection they are intended to treat may become worse.
Antibiotic resistance occurs when bacteria evolve to become resistant to the drugs used to treat them. This happens when bacteria are exposed to antibiotics, which kills off the weaker bacteria, leaving the stronger, more resistant ones behind. Over time, these bacteria become more and more resistant to the drugs, reducing their effectiveness.
Request for a sample data and methodology of Report: https://www.globalinsightservices.com/request-sample/GIS25770
Antibiotic resistance is a major health concern due to the potential for serious, life-threatening infections. When antibiotics are no longer effective at treating certain infections, it can lead to increased hospital visits, longer hospital stays, and higher mortality rates.
Key Trends
Antibiotic resistance technology is a growing field of research that is being used to develop new and more effective drugs for the treatment of bacterial infections. This technology is based on the concept that bacteria can develop resistance to antibiotics over time, which can lead to the ineffectiveness of certain drugs. As such, the development of new antibiotics that are able to target resistant bacteria is of great importance.
The key trends in antibiotic resistance technology can be divided into two main categories: technological advances and research into new antibiotics. Technological advances include the use of genomics, which has enabled researchers to identify the genes responsible for antibiotic resistance in bacteria. This knowledge can be used to develop drugs that target these genes, as well as to identify new antibiotics that can combat resistant bacteria. In addition, advances in nanotechnology and drug delivery systems have enabled the development of new drugs that are more effective and have fewer side effects.
Key Drivers
Antibiotic resistance is a growing global health concern as the number of infections caused by antibiotic-resistant bacteria is on the rise. The World Health Organization (WHO) has declared antibiotic resistance as one of the top ten global health threats of the 21st century. The global antibiotic resistance market is estimated to reach USD 11.57 billion in 2020 and is expected to register a CAGR of 11.1% from 2020 to 2027.
The key drivers of the antibiotic resistance market include the increasing prevalence of antibiotic-resistant infections, rising healthcare expenditure, and the development of novel treatments.
Firstly, the increasing prevalence of antibiotic-resistant infections is the primary driver of the antibiotic resistance market. Antibiotic resistance occurs when bacteria become resistant to the drugs used to treat them, resulting in infections that are harder to treat and more expensive to treat. According to the World Health Organization, antibiotic resistance is one of the biggest threats to global health, food security, and development today. The increasing prevalence of antibiotic-resistant infections has led to an increased demand for effective treatments, driving the growth of the antibiotic resistance market.
Secondly, rising healthcare expenditure is another major driver of the antibiotic resistance market. The rising cost of healthcare, coupled with the increasing prevalence of antibiotic-resistant infections, has led to an increased demand for effective treatments. This has resulted in a rise in healthcare expenditure, driving the growth of the antibiotic resistance market.
Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS25770
Market Segmentation
The market can be segmented by disease, pathogen, drug class, mechanism of action and region. By disease, the market can be divided into cuti, ciai, and bsi. By pathogen, the market can be divided into e. coli, and k. . pneumonia. By drug class, the market can be divided into oxazolidinones and cephalosporin. By mechanism of action, the market can be divided into cell wall, and protein synthesis inhibitors. By region, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World.
Key Players
The market includes players such as Achaogen Inc (U.S.), Nabriva Therapeutics plc, (Ireland), BioVersys AG (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Destiny Pharma plc (U.K.), Armata Pharmaceuticals, Inc. (U.S.), West Way Health (Ireland), The Medicines Company (U.S.), Merck & Co., Inc. (Germany), and Pfizer Inc. (U.S.).
Purchase this report and Get a flat 50% Discount: https://www.globalinsightservices.com/checkout/single_user/GIS25770
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700